CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss	Total
Beginning Balance at Dec. 31, 2017	$ 20,931	$ 80,395	$ (997)	$ 100,329
Balances (in shares) at Dec. 31, 2017	5,943,044
Increase (Decrease) in Stockholders' Equity
Common stock issued - stock grants	$ 64			64
Common stock issued - stock grants (in shares)	12,198
Stock compensation expense	$ 175			175
Other comprehensive Income (loss)			(2,481)	(2,481)
Net income		12,430		12,430
Dividends declared		(3,724)		(3,724)
Ending Balance at Dec. 31, 2018	$ 21,170	89,101	(3,478)	106,793
Balances (in shares) at Dec. 31, 2018	5,955,242
Increase (Decrease) in Stockholders' Equity
Common stock issued - stock grants	$ 295			295
Common stock issued - stock grants (in shares)	24,680
Stock compensation expense	$ 220			220
Common stock purchased and retired	$ (238)	(1,306)		(1,544)
Common stock purchased and retired (in shares)	(66,000)
Other comprehensive Income (loss)			4,391	4,391
Net income		13,153		13,153
Dividends declared		(4,045)		(4,045)
Ending Balance at Dec. 31, 2019	$ 21,447	$ 96,903	$ 913	$ 119,263
Balances (in shares) at Dec. 31, 2019	5,913,922